Searchable abstracts of presentations at key conferences in endocrinology

ea0099p548 | Pituitary and Neuroendocrinology | ECE2024

Effects of MIA-602, GHRH receptor antagonist, on emotional disorders in mice

Loreta Libero Maria , Recinella Lucia , V. Schally Andrew , Salvatori Roberto , Brunetti Luigi , Leone Sheila

The role of growth hormone-releasing hormone (GHRH) in brain function has been suggested. Recent behavior studies by our group clearly demonstrate a powerful anxiolytic and antidepressant-like effects of a novel growth hormone releasing hormone (GHRH) antagonist of MIAMI class, MIA-690, probably related to modulatory effects on the inflammatory and oxidative status [1]. Our investigation in this work was focused on the potential beneficial effects of MIA-602, another recently ...

ea0099p396 | Late-Breaking | ECE2024

Growth hormone-releasing hormone (GHRH) antagonists enhance radiosensitivity in non-small cell lung cancer cells

Gesmundo Iacopo , Pedrolli Francesca , Romana Giglioli Francesca , Bertoldo Alessia , Gregorc Vanesa , Sapino Anna , Righi Luisella , Cai Renzhi , Sha Wei , Giulio Papotti Mauro , Ghigo Ezio , V. Schally Andrew , Ricardi Umberto , Granata Riccarda

Growth hormone-releasing hormone (GHRH), apart from stimulating GH secretion in the pituitary, exerts many peripheral functions, including stimulation of cell proliferation and survival. In fact, GHRH and GHRH receptors (GHRH-Rs) are expressed in different cancer cell types, where they promote proliferation and survival. Conversely, GHRH antagonists exert antineoplastic activities in several tumors, including lung cancer, one of the leading causes of death by cancer worldwide....